Procurement Summary
Country : Germany
Summary : Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Oxybutynin, Atc Code: G04bd04 for the Period from April 1St, 2023 to March 31St, 2025
Deadline : 05 Feb 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 79640416
Document Ref. No. : 127151-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The present announcement serves to conclude drug discount agreements in accordance with § 130a Paragraph 8 SGB V for the active substance(s) mentioned under point II.1.1). It is not about the award of public contracts within the meaning of Directive 2014/24/EU or Sections 97 ff GWB. contractual partner kann every pharmaceutical company according to § 4 Abs. 18 AMG. According to the case law of the ECJ, such approval procedures are not necessarily subject to public procurement law, since there is no competition due to the lack of a selection decision. The notice serves as an invitation toConclusion of discount agreements with the same conditions that apply to all contractual partners and are non-dispositive, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which must be submitted to the person named under I.3).Contact point can be requested.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 2023/S 043-127151
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Other
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date: 2023-02-24
Publish Date : 2023-03-01
Submission Date : 2025-02-05
Documents
Tender Notice